C07D 233/90
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D233/90 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 793 US grants and 650 published applications in this corpus.
Search patents in C07D- Granted patents
- 793
- Published applications
- 650
- Assignees
- 402
- Inventors
- 2,677
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 12 | 0 |
| 1978 | 5 | 0 |
| 1979 | 14 | 0 |
| 1980 | 20 | 0 |
| 1981 | 8 | 0 |
| 1982 | 9 | 0 |
| 1983 | 7 | 0 |
| 1984 | 9 | 0 |
| 1985 | 7 | 0 |
| 1986 | 14 | 0 |
| 1987 | 6 | 0 |
| 1988 | 10 | 0 |
| 1989 | 18 | 0 |
| 1990 | 10 | 0 |
| 1991 | 14 | 0 |
| 1992 | 15 | 0 |
| 1993 | 22 | 0 |
| 1994 | 12 | 0 |
| 1995 | 9 | 0 |
| 1996 | 12 | 0 |
| 1997 | 10 | 0 |
| 1998 | 18 | 0 |
| 1999 | 17 | 0 |
| 2000 | 15 | 0 |
| 2001 | 23 | 3 |
| 2002 | 19 | 19 |
| 2003 | 19 | 22 |
| 2004 | 18 | 33 |
| 2005 | 12 | 38 |
| 2006 | 20 | 22 |
| 2007 | 20 | 30 |
| 2008 | 12 | 33 |
| 2009 | 12 | 33 |
| 2010 | 23 | 36 |
| 2011 | 22 | 22 |
| 2012 | 19 | 32 |
| 2013 | 29 | 26 |
| 2014 | 36 | 34 |
| 2015 | 26 | 32 |
| 2016 | 31 | 21 |
| 2017 | 27 | 24 |
| 2018 | 17 | 24 |
| 2019 | 13 | 18 |
| 2020 | 12 | 27 |
| 2021 | 21 | 20 |
| 2022 | 15 | 20 |
| 2023 | 15 | 30 |
| 2024 | 10 | 27 |
| 2025 | 9 | 8 |
| 2026 | 10 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Imidazole compounds as inhibitors of ENPP122 Sep 2026US 12,741,963 B2Stingray Therapeutics, Inc.
- Continuous method for preparing tricyanoimidazole28 Jul 2026US 12,692,237 B2Uchicago Argonne, LLC
- 5-membered heteroaryl carboxamide compounds for treatment of HBV16 Jun 2026US 12,655,130 B2Assembly Biosciences, Inc.
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugs12 May 2026US 12,622,893 B2ADS Therapeutics LLC
- 5-membered heteroaryl carboxamide compounds for treatment of hbv17 Sep 2026US 2026/0274823 A1Assembly Biosciences, Inc.
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
- Methods of preparing substituted pyrazolopyrimidines3 Sep 2026US 2026/0258046 A1KSQ Therapeutics, Inc.
- Analogs for the treatment of disease27 Aug 2026US 2026/0250267 A1Insilico Medicine IP Limited
- Novel ionizable lipid compounds for nucleic acid delivery30 Jul 2026US 2026/0216087 A1Celon Pharma S.A.
Most cited
By later US patents
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Cyclic protein tyrosine kinase inhibitors134US 6,596,746 B1Bristol-Myers Squibb Company · 2003
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Angiotensin II receptor blocking imidazoles119US 5,138,069 AE. I. Du Pont de Nemours and Company · 1992